期刊文献+
共找到54篇文章
< 1 2 3 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Are Fetuses Affected by Gastroschisis Benefited from Prenatal Maternal Corticosteroid Use and Early Parturition?
7
作者 Mateus Guimaraes Massimo Anna Paula Auada Kopaz +1 位作者 Neil Ferreira Novo Willy Marcus Franca 《Surgical Science》 2019年第5期154-163,共10页
Introduction: Gastroschisis (G) is a congenital defect of the abdominal walls through which intestinal herniation and permanent exposure to amniotic liquid (AL) and its components are developed at the end of gestation... Introduction: Gastroschisis (G) is a congenital defect of the abdominal walls through which intestinal herniation and permanent exposure to amniotic liquid (AL) and its components are developed at the end of gestation. G affects mostly fetuses from young mothers under 25 - 29 years old, but it occurs more often in fetuses of mothers’ ages between 12 - 15 years old. Some authors assert that it is not the low weight, nor the low gestational age that influences mortality. In addition to morphological alterations, histological alterations are characterized by disorganization, distribution and the degree of ganglia maturity and myenteric plexuses. The literature describes parturition anticipation of G disease carriers to minimize damages to intestinal loops. There are studies suggesting corticosteroids at the end of gestation in order to avoid morphological and histological damages to the intestinal loop. Objective: Identify if live newborn infants delivery anticipation, that is, gestational date less than 37 weeks and prenatal maternal use of corticosteroid were benefited from early enteral diet, namely, less than 10 post-surgery days. Material and Method: From 33 newborns researched in the period from 2010 to 2014;28 newborns full records were included in the study with 15.2% mortality rate. These newborns were divided in 3 groups according to maternal age: 6 newborns from mothers’ age between 16 - 20 years old (Group 1);14 newborns from mothers’ age between 21 - 25 years old (Group 2) and 8 newborns from mothers’ age between 26 - 29 years old (Group 3). Gestational age at birth and prenatal maternal usage of corticosteroid and beginning oral feeding were assessed. Results: From 28 newborns, 19 mothers ingested prenatal corticosteroid and 16 newborns received the first enteric diet 10 days before and 3 days later. The mothers of the other 9 newborns were not treated with corticosteroid;only 3 newborns were fed before 10 days and 6 were fed later (p = 0.0016). Regarding gestational age, 17 newborns were born before 37 weeks and their 1st enteral diet was offered before 10 days. From the 11 newborns born after 37 weeks, only 4 received the 1st enteral diet before 10 days (p = 0.015). Conclusion: Newborn infants born with gestational age below 37 weeks, whose mothers received prenatal corticosteroid, were benefited with the first enteral diet before 10 postoperative days. 展开更多
关键词 GASTROSCHISIS Preterm Delivery Maternal use of corticosteroid First Enteral Feeding
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
8
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
9
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
10
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
慢阻肺患者应用双支扩剂加ICS治疗的临床效果分析
11
作者 桑艳平 《中国实用医药》 2024年第8期107-110,共4页
目的 为慢性阻塞性肺疾病(慢阻肺)患者实施双支气管扩张剂(双支扩剂)加吸入性糖皮质激素(ICS)治疗,分析其临床治疗有效性。方法 200例慢阻肺患者为研究对象,借助双色球抽取方法分为研究组与对照组,每组100例。对照组行常规治疗,研究组... 目的 为慢性阻塞性肺疾病(慢阻肺)患者实施双支气管扩张剂(双支扩剂)加吸入性糖皮质激素(ICS)治疗,分析其临床治疗有效性。方法 200例慢阻肺患者为研究对象,借助双色球抽取方法分为研究组与对照组,每组100例。对照组行常规治疗,研究组在对照组基础上行双支扩剂加ICS治疗。比较两组临床指标、肺功能指标[呼气流量峰值(PEF)、用力肺活量(FVC)、第1秒用力呼气容积(FEV1)]、炎症标志物[C反应蛋白(CRP)、降钙素原(PCT)]、治疗效果、不良反应发生率。结果 研究组患者的住院天数为(15.55±2.12)d,咳嗽天数为(4.25±3.22)d,肺部哮鸣音天数为(3.50±1.08)d;对照组患者的住院天数为(25.40±2.65)d,咳嗽天数为(6.75±1.06)d,肺部哮鸣音天数为(6.00±1.00)d。研究组的住院天数、咳嗽天数、肺部哮鸣音天数均短于对照组,存在显著差异(P<0.05)。治疗后,研究组患者的PEF、FVC、FEV1显著高于对照组,存在显著差异(P<0.05)。治疗后,研究组的CRP为(9.12±0.43)mg/L、PCT为(0.18±0.04)ng/ml,对照组的CRP为(15.80±2.08)mg/L、PCT为(1.23±0.11)ng/ml,研究组CRP、PCT更低,存在显著差异(P<0.05)。研究组患者总有效率为98.00%(98/100),对照组患者总有效率为73.00%(73/100),研究组总有效率高于对照组,存在显著差异(P<0.05)。研究组患者不良反应发生率为0.20%(2/100),对照组患者不良反应发生率为11.00%(11/100),研究组不良反应发生率低于对照组,存在显著差异(P<0.05)。结论 实施双支扩剂加ICS治疗,能够有效地改善慢阻肺患者的病情,降低了患者的炎症反应,延缓了病情进展,提高了患者的生活质量,值得推广和应用。 展开更多
关键词 慢性阻塞性肺疾病 双支气管扩张剂 吸入性糖皮质激素 治疗效果
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
12
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
13
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
斑秃患者189例的疗效与临床和病理的相关关系 被引量:13
14
作者 蔡泽明 赵莹 +5 位作者 杨建 西兰 张斌 巩毓刚 陈闻纳 章星琪 《中国皮肤性病学杂志》 CAS 北大核心 2011年第7期538-541,共4页
目的探讨斑秃患者不同临床表现及病理改变对疗效的影响。方法通过回顾性调查189例斑秃患者予复方甘草酸苷片、糖皮质激素序贯治疗的疗效,分析不同临床表现和检验指标对疗效的影响;并对其中84例行皮损处边缘活检,以分析病理改变对疗效的... 目的探讨斑秃患者不同临床表现及病理改变对疗效的影响。方法通过回顾性调查189例斑秃患者予复方甘草酸苷片、糖皮质激素序贯治疗的疗效,分析不同临床表现和检验指标对疗效的影响;并对其中84例行皮损处边缘活检,以分析病理改变对疗效的影响。结果斑秃类型、脱发面积、发病年龄及病理改变中的嗜酸性粒细胞浸润、浅层毛囊细胞破坏影响疗效,家族史、甲损害、IgE水平、炎症分期、淋巴细胞浸润程度不影响疗效。普全秃、发病年龄早(≤20岁)、病程长(>12月)和脱发面积大(>60%)、病理未伴有毛囊上皮细胞破坏、嗜酸性粒细胞浸润的疗效差。结论病程短、脱发面积小、斑片型、病理伴毛囊破坏及嗜酸细胞浸润可用复方甘草酸苷治疗,反之疗效差者,可选用激素治疗。 展开更多
关键词 斑秃 病理改变 临床表现 疗效 复方甘草酸苷 类固醇激素
下载PDF
糖皮质激素联合大剂量免疫球蛋白成功治疗重型新型冠状病毒肺炎1例临床经验分析 被引量:4
15
作者 郑楷炼 张优 +5 位作者 王琼娅 徐莹 王辉 孔祥毓 李奕 董宇超 《第二军医大学学报》 CAS CSCD 北大核心 2020年第2期181-185,共5页
目的报道1例重型新型冠状病毒肺炎(COVID-19)应用糖皮质激素联合免疫球蛋白救治成功的病例,分享重型COVID-19的临床治疗经验。方法和结果患者为武汉市医务工作者,起病前曾多次接触COVID-19患者,2020年1月16日起无明显诱因出现咳嗽伴少... 目的报道1例重型新型冠状病毒肺炎(COVID-19)应用糖皮质激素联合免疫球蛋白救治成功的病例,分享重型COVID-19的临床治疗经验。方法和结果患者为武汉市医务工作者,起病前曾多次接触COVID-19患者,2020年1月16日起无明显诱因出现咳嗽伴少许白黏痰,1月22日出现发热(最高38.5℃)并入院治疗,查CT示双肺散在少量渗出,予口服奥司他韦、静脉输注莫西沙星及头孢哌酮舒巴坦钠、加强营养等治疗。1月26日出现胸闷气急,咽拭子检测示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核酸阳性,CT示双肺渗出较前增加。1月28日气急加重,输注甲泼尼龙(40 mg,每天1次)和人免疫球蛋白(10 g,每天1次)治疗。1月30日体温升高至40.7℃,气急进一步加重,脉搏血氧饱和度(SpO2)降至83%(吸氧量10 L/min),淋巴细胞计数降至0.5×10^9/L,调整甲泼尼龙剂量(40 mg,每12 h 1次)及人免疫球蛋白剂量(20 g,每天1次),增加胸腺法新(1.6 mg,皮下注射,每天1次)等治疗,体温恢复正常,胸闷气急逐渐好转。1月31日SpO288%(吸氧量10 L/min),复查胸部CT提示双肺大片渗出影。2月2日SpO295%(吸氧量5 L/min),开始逐渐减少甲泼尼龙用量。2月3日复查胸部CT提示肺部炎症较前好转,2月4日及9日复查咽拭子示SARS-CoV-2核酸阴性。结论早期及轻型COVID-19患者应尽量避免使用糖皮质激素,当患者出现呼吸衰竭失代偿时可适当使用糖皮质激素降低免疫指标,但剂量不宜过高,必要时可予大剂量免疫球蛋白帮助平衡免疫功能。 展开更多
关键词 新型冠状病毒肺炎 糖皮质激素 免疫球蛋白 救治经验
下载PDF
葛根素联合激素冲击治疗急性非动脉炎性前部缺血性视神经病变 被引量:4
16
作者 于彬科 仝警安 王红艳 《浙江中医药大学学报》 CAS 2009年第2期211-212,共2页
[目的]观察葛根素联合激素冲击疗法对非动脉炎性前部缺血性视神经病变(NAION)水肿期的疗效。[方法]对临床确诊的NAION经眼底检查及OCT检查确诊为水肿期患者58例60只眼,其中29例30只眼给予葛根素联合激素冲击治疗(治疗组);另外29例30只... [目的]观察葛根素联合激素冲击疗法对非动脉炎性前部缺血性视神经病变(NAION)水肿期的疗效。[方法]对临床确诊的NAION经眼底检查及OCT检查确诊为水肿期患者58例60只眼,其中29例30只眼给予葛根素联合激素冲击治疗(治疗组);另外29例30只眼给予激素冲击疗法配合复方樟柳碱(CA)治疗(对照组)。[结果]治疗组视力提高程度明显好于对照组,两组间差异有统计学意义(P<0.05);治疗组与对照组在视野改善方面差异比较有统计学意义(P<0.01);OCT检查,治疗组减轻视盘厚度好于对照组,两组间差异有统计学意义(P<0.05)。[结论]葛根素联合激素冲击疗法在NA10N水肿期治疗有较好的治疗效果。 展开更多
关键词 视神经病变 葛根素 泼尼松龙 复方樟柳碱 疗效观察
下载PDF
霉酚酸治疗药物监测有利于减少肾移植受者皮质类固醇激素的用量 被引量:1
17
作者 杨洋 周佩军 +3 位作者 徐达 王祥慧 邵琨 师天明 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第10期1534-1538,共5页
目的对处于免疫抑制维持治疗期的肾移植受者,在进行霉酚酸(MPA)治疗药物监测(TDM)并指导霉酚酸酯(MMF)合理应用的基础上,减少皮质类固醇激素的用量并评价其有效性及安全性。方法 80例肾移植受者,均接受CsA+MMF+Pred三联免疫抑... 目的对处于免疫抑制维持治疗期的肾移植受者,在进行霉酚酸(MPA)治疗药物监测(TDM)并指导霉酚酸酯(MMF)合理应用的基础上,减少皮质类固醇激素的用量并评价其有效性及安全性。方法 80例肾移植受者,均接受CsA+MMF+Pred三联免疫抑制方案治疗,随机分为MPA TDM组和对照组。MPA TDM组患者,通过有限采样法的简化公式,计算肾移植受者MPA血药浓度-时间曲线下面积(AUC),并根据MPAAUC调整MMF剂量,使MPA-AUC0~12 h达到30~60 mg·h^-1·L^-1,皮质类固醇激素(Pred)剂量减少50%以上。对照组患者,采用相对固定的MMF剂量,同时皮质类固醇激素不减量。比较2组患者移植物排斥反应、各种不良反应的发生率,以及空腹血糖的差异。结果 MPA TDM组和对照组患者中,移植肾功能、移植物排斥反应、各种不良反应的发生率、CsA及MMF的服用剂量差异无统计学意义(P〉0.05);Pred的用量分别为(2.77±0.79)mg/d和(6.00±1.77)mg/d,差异有统计学意义(P〈0.05);空腹血糖水平分别为(5.36±0.50)mmol/L和(5.78±1.19)mmol/L,差异有统计学意义(P〈0.05)。结论免疫抑制维持治疗期的肾移植受者,在进行MPA治疗药物监测并合理调整MMF剂量的基础上,可安全、有效地减少皮质类固醇激素的用量。 展开更多
关键词 肾移植 霉酚酸 治疗药物监测 皮质类固醇 低剂量
下载PDF
COPD合并继发性慢性肾上腺皮质功能减退患者的肾上腺皮质激素治疗方案探讨——附60例报告 被引量:3
18
作者 赵云峰 张立 吴学玲 《新医学》 2009年第5期292-294,297,共4页
目的:探讨COPD合并继发性慢性肾上腺皮质功能减退患者的肾上腺皮质激素治疗方法。方法:60例COPD急性加重期合并继发性慢性肾上腺皮质功能减退患者随机分为激素逐渐减量组(A组)和非激素逐渐减量组(B组)各30例,同期选取16名健康志愿者作... 目的:探讨COPD合并继发性慢性肾上腺皮质功能减退患者的肾上腺皮质激素治疗方法。方法:60例COPD急性加重期合并继发性慢性肾上腺皮质功能减退患者随机分为激素逐渐减量组(A组)和非激素逐渐减量组(B组)各30例,同期选取16名健康志愿者作为对照组。分别检测3组入院时、出院后第3个月、第6个月、第9个月、第12个月、第15个月、第18个月的血浆皮质醇水平,记录18个月观察期内A组、B组急性加重发作的次数及激素的总用量,比较上述指标的差异。结果:A组血浆皮质醇水平于出院后第12个月恢复正常,B组在18个月观察期内血浆皮质醇水平一直低于对照组。A组18个月内急性加重发作(0.7±0.3)次,明显少于B组的(4.7±1.3)次(P<0.01);A组18个月内泼尼松总用量(2 055±310)mg,明显少于B组的(2 675±518)mg(P<0.05)。结论:对于COPD合并继发性慢性肾上腺皮质功能减退患者,宜在控制COPD急性加重期症状后,逐渐减少激素的用量并长期维持,以减少急性加重的发作次数和激素的总用量。动态测定血浆皮质醇水平有利于及时了解COPD合并继发性慢性肾上腺皮质功能减退患者的肾上腺皮质功能。 展开更多
关键词 慢性阻塞性肺疾病 继发性慢性肾上腺皮质功能减退症 皮质醇 肾上腺皮质激素 治疗方案
下载PDF
黄芪注射液联合糖皮质激素治疗支气管哮喘急性发作期患者疗效及对炎性因子的影响 被引量:30
19
作者 董辉 《河北医药》 CAS 2017年第5期683-685,690,共4页
目的探讨黄芪注射液联合糖皮质激素对支气管哮喘急性发作期患者疗效及炎性因子的影响。方法选取收治的支气管哮喘急性发作期患者95例,依据随机数字表法随机分为观察组(n=48)和对照组(n=47)。对照组给予布地奈德气雾剂,观察组在对照组基... 目的探讨黄芪注射液联合糖皮质激素对支气管哮喘急性发作期患者疗效及炎性因子的影响。方法选取收治的支气管哮喘急性发作期患者95例,依据随机数字表法随机分为观察组(n=48)和对照组(n=47)。对照组给予布地奈德气雾剂,观察组在对照组基础上结合黄芪注射液。2组疗程均为14 d。比较2组治疗疗效,治疗前后第1秒用力呼气容积(FEV1)、炎性因子[白介素-18(IL-18)、超敏C-反应蛋白(hs-CRP)、基质金属蛋白-酶9(MMP-9)、血管内皮生长因子(VEGF)]、主要症状体征积分变化,及药物不良反应情况。结果观察组治疗总有效率(95.83%)高于对照组(76.60%)(P<0.05);2组FEV1治疗后与治疗前比较明显增加(P<0.05);观察组FEV1治疗后高于对照组(P<0.05);2组血清IL-18、hs-CRP、MMP-9、VEGF水平治疗后明显降低(P<0.05);观察组血清IL-18、hs-CRP、MMP-9、VEGF水平治疗后低于对照组(P<0.05);2组咳嗽、喘息、哮鸣音积分治疗后明显降低(P<0.05);观察组咳嗽、喘息、哮鸣音积分治疗后低于对照组(P<0.05);2组不良反应发生率比较差异无统计学意义(P>0.05)。结论黄芪注射液联合糖皮质激素治疗支气管哮喘急性发作期患者疗效显著,其作用可能与降低IL-18、hs-CRP、MMP-9、VEGF水平相关,且可改善症状、体征,安全性良好,值得研究。 展开更多
关键词 黄芪注射液 糖皮质激素 支气管哮喘 急性发作期 疗效 炎性因子
下载PDF
甲状腺相关眼病上睑退缩的治疗 被引量:5
20
作者 颜建华 吴中耀 《眼视光学杂志》 2005年第1期50-52,56,共4页
目的 :探讨甲状腺相关眼病上睑退缩的治疗方法。方法 :回顾分析临床资料完整的 90例 1 2 3眼甲状腺相关眼病上睑退缩的治疗效果。治疗方法包括保守观察、全身和局部糖皮质激素治疗、局部肉毒杆菌毒素注射和手术治疗等。治疗后平均随访 1... 目的 :探讨甲状腺相关眼病上睑退缩的治疗方法。方法 :回顾分析临床资料完整的 90例 1 2 3眼甲状腺相关眼病上睑退缩的治疗效果。治疗方法包括保守观察、全身和局部糖皮质激素治疗、局部肉毒杆菌毒素注射和手术治疗等。治疗后平均随访 1 .4年。结果 :用全身和局部糖皮质激素治疗 34例 4 9眼中 ,上睑退缩完全消失 4例 6眼 ,明显改善1 3例 2 0眼 ,无效 1 7例 2 3眼 ;局部肉毒杆菌毒素注射 2 0例2 6眼中 ,上睑退缩完全消失 8例 9眼 ,明显改善 9例 1 1眼 ,无效 3例 6眼 ,持续时间 6w至 2年 ,注射后并发上睑下垂 4例 5眼 ;提上睑肌延长术 1 1例 1 5眼中 ,术后上睑退缩完全消失 7例 1 0眼 ,明显改善 2例 3眼 ,复发 1例 1眼 ,轻度过矫1例 1眼 ;上睑退缩伴患眼下斜视 1 5例 1 5眼 ,行患眼下直肌后退术 ,其中术后上睑退缩完全消失 1 4例 1 4眼 ,明显改善 1例 1眼 ;1 0例 1 8眼未作任何治疗 ,经平均 2年随访观察发现2例 4眼上睑退缩完全消失 ,1例 2眼有明显改善。结论 :甲状腺相关眼病上睑退缩宜采用综合治疗措施。发病初期或活动期病例用全身和局部糖皮质激素和局部注射肉毒杆菌毒素治疗效果好 ,静止期或保守治疗效果不好的患者宜行提上睑肌延长术治疗 ,伴有下斜视的患者行斜视矫正术可同时矫正斜视与上睑退缩。 展开更多
关键词 上睑退缩 治疗 甲状腺相关眼病 局部 肉毒杆菌毒素 糖皮质激素 全身 和局 结论 保守
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部